Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the ReZolve™ Sirolimus-Eluting Bioresorbable Coronary Stent

NCT01262703 is registered in ClinicalTrials.gov with REVA Medical, Inc. as lead sponsor.

NCT NCT01262703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01262703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the ReZolve™ Sirolimus-Eluting Bioresorbable Coronary Stent
Lead sponsor
REVA Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2011
Completion date
December 31, 2018
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary artery disease, coronary artery stenosis, coronary disease, coronary restenosis, myocardial ischemia